SCHEMBL6426236

SCHEMBL6426236

O=C1C(Cl)=C(c2ccccn2)C(=O)N1Cc1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPK1 P28482 3/20 0.46
LMNA P02545 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
HTT P42858 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MCOLN3 Q8TDD5 1/20 0.45
KDM4E B2RXH2 1/20 0.44
TP53 P04637 1/20 0.44
HPGD P15428 1/20 0.44
NR1H2 P55055 2/20 0.43
NR1H3 Q13133 2/20 0.43
F2 P00734 1/20 0.43
PLG P00747 1/20 0.43
ELANE P08246 1/20 0.43
CTSG P08311 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6429956 0.85 MAPT (0.43) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL6431729 0.78 NR1H2 (0.51) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL5049894 0.77 ELANE (0.64) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL6442280 0.77 MAPT (0.46) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL4694322 0.75 ALDH1A1 (0.59) MAPTALDH1A1MAPK1LMNAMEN1
SCHEMBL6466541 0.74 L3MBTL1 (0.51) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL4688137 0.73 KDM4E (0.51) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL6426931 0.72 MAPT (0.48) MAPTALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL8314773 0.71 ALDH1A1 (0.72) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL6444746 0.71 RAD51 (0.50) MAPTALDH1A1MAPK1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed